secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lomond Therapeutics Holdings, Inc. (—)
CIK:        0001900520
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001213900-24-095442
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 3.02, 1.01, 3.03, 4.01, 5.01, 5.02, 5.03, 5.06, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SPAC Venetian-1 completes reverse merger with biotech Lomond; raises $43.9M in PIPE
--------------------------------------------------------------------------------

- Merger closed Nov 1, 2024; Venetian-1 changed name to Lomond Therapeutics Holdings, Inc.
- Legacy Lomond stockholders received 14,420,383 shares; 3,625,000 pre-merger shares forfeited.
- Private placement raised $43.9M: 8,241,375 shares at $4.00 plus SAFE conversions at $3.20/$3.60.
- Options for 4,329,617 shares at $1.30 assumed; 2024 Equity Incentive Plan adopted.
- Lock-up agreements for directors/officers; company must file resale registration statement within 20 trading days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1900520/000121390024095442/0001213900-24-095442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1900520/000121390024095442/ea0219762-8k_lomond.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-095442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer